Wie produceert Comirnaty KP.2 30 µg/dose inj. disp. i.m. vial?

BioNTech Manufacturing GmbH (BE)

Tot welke ATC-klasse behoort Comirnaty KP.2 30 µg/dose inj. disp. i.m. vial?

Comirnaty KP.2 30 µg/dose inj. disp. i.m. vial: ATC J07BN01 Covid-19, RNA-based Vaccine. ATC is de WHO-classificatie van geneesmiddelen.

OTC

Comirnaty KP.2 30 µg/dose inj. disp. i.m. vial: Dispersion for injection (Intramuscular use)

Dispersion for injection

INN: Cemivameran, COVID-19 mRNA Vaccine (nucleoside modified)

Bijgewerkt: 2026-05-12

Verkrijgbaar in:

🇩🇪🇬🇧

Vorm

Dispersion for injection

Dosering

—

Toedieningsweg

Intramuscular use

Bewaring

—

Over dit product

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.